Biotech Values

[oc631]

Blade,

I agree with you the lawsuit is without merit (another "blunt layman"). Perhaps this is the first punch in a dirty fight against Teva but I would expect the suit to be thrown out of court (unless the FDA approves T-Enox before that happens.)

By this, I mean, that MNTA is attacking TEVA's business strategy of attempting to provide Mr Market with assurances that TEVA's generic Lovenox is near imminent approval, and, thereby, injuring MNTA's business and causing its stock to be undervalued and, therefore, harming MNTA shareholders.

Dew and others on this MB have made an excellent case for T-Enox not to be taken seriously (and I hold the utmost gratitude for the work done - I am long MNTA). Yet it's alarming how many people on this MB discount, or not even address, the possibility that this lawsuit was a result of MNTA finding out, through other sources, that T-Enox in fact may be approved. I hope to hear Wheeler continue to discredit the chance of T-Enox approval in the future so I myself can discount the possibility. Until then I hold my opinion that yours, and not yours alone, is a dangerously cynical attitude.